Related Experiment Video
Updated: Jun 26, 2026
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic
Zhi-Hua Yang1,2, Yue Peng1,2, Rong Shang1,2
1Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Background:
Splenic flexure colon cancer (SFCC) is a rare gastrointestinal malignancy distinguished by its unique anatomical location and dual vascular supply. Nevertheless, its clinical behavior, prognostic outcomes, and underlying risk factors remain inadequately defined.
Methods:
A two-cohort study design enrolled 478 patients with stage II-III colon cancer. A colon cancer cohort (2012-2017) compared survival outcomes across tumor locations, while a separate SFCC-specific cohort (2012-2022) evaluated prognostic biomarkers in SFCC patients. A composite nutrition-inflammation integrating index (NII), derived from FPMLR and FPNLR, was developed and evaluated using Kaplan-Meier curves and Cox regression models.
Results:
Significantly worse recurrence-free survival (RFS) and overall survival (OS) were observed in patients with SFCC or ascending colon cancer (ACC) compared with those with transverse or descending colon cancers (TCC or DCC), in both colon cancer cohort and SFCC cohort. SFCC was characterized by higher TNM stage, lymph metastasis status, large tumor-size, poor differentiation, and inflammation-nutrition imbalance relative to TCC and DCC. Multivariate Cox regression analysis identified the NII as an independent prognostic factor for OS in SFCC (adjusted HR = 3.834, 95%CI=1.452-10.122). Importantly, NII remained significantly associated with unfavorable clinical outcomes in subgroups, including patients with normal level of CA19-9, stage III disease, and those who underwent adjuvant chemoradiotherapy.
Conclusion:
SFCC may represent a potentially distinct prognostic subtype of colon cancer that appears to be associated with relatively aggressive pathological features and a persistently elevated systemic inflammatory state. The NII may serve as an exploratory indicator of the chronic inflammation-nutrition imbalance in these patients, and it may offer modest added value for risk stratification and individualized management. Further large-scale, multicenter prospective studies are warranted to validate these findings.
Related Concept Videos
01:27Diverticular Disease of the Colon
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...